Literature DB >> 18520581

High-frequency sensorineural hearing loss after stapedectomy.

Michele Bauchet St Martin1, Elaine N Rubinstein, Barry E Hirsch.   

Abstract

OBJECTIVE: To describe the pattern and duration of high frequency sensorineural hearing loss after stapedectomy. STUDY
DESIGN: Retrospective case series.
SETTING: Tertiary referral center. PATIENTS: All patients who underwent stapedectomy by the senior author during the period between January 1, 1998, and October 1, 2005, with preoperative, 4- to 6-week postoperative, and at least 9-month postoperative audiograms were included. Fifty-three patients met the inclusion criteria, with surgeries performed on 61 ears. INTERVENTION(S): Stapedectomy was performed using a CO2 laser. MAIN OUTCOME MEASURE(S): Mean preoperative and postoperative pure-tone bone thresholds, mean preoperative and postoperative pure-tone air thresholds, and hearing outcomes for 4,000 Hz bone conduction (BC) and 8,000 Hz air conduction (AC) based on the patient's age and interval after the operative procedure.
RESULTS: : Mean BC thresholds at 4,000 Hz BC worsened by 6 dB at 4 to 6 weeks and improved by 3 dB by 9 months. There was an 8-dB average loss at 8,000 Hz AC at 4 to 6 weeks with a gain of 4 dB by 9 months. Patients older than 40 years were 4 times more likely to experience early loss at 4,000 Hz BC when preoperative thresholds were held constant. The late outcome for hearing loss was dependent more on the preoperative threshold than was the age of the patient. At 8,000 Hz AC, the preoperative hearing threshold was a predictor of early and late hearing loss at 8,000 Hz.
CONCLUSION: High-frequency sensorineural hearing loss is initially seen after stapes surgery, and improvement does occur over time. When preoperative hearing threshold is held constant, patients older than 40 years are more likely to experience short-term hearing loss at high frequencies than patients younger than 40 years. Age was not a predictor of postoperative high-frequency hearing loss in the long term.

Entities:  

Mesh:

Year:  2008        PMID: 18520581     DOI: 10.1097/MAO.0b013e318172d6a3

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Delaying partial stapedectomy for otosclerosis: effects on long-term hearing outcomes following surgery.

Authors:  Anastasios Maniakas; Jade Nehme; Jean-Jacques Dufour; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-08       Impact factor: 2.503

2.  Does stapedotomy improve high frequency conductive hearing?

Authors:  Prithwijit Roychowdhury; Marc D Polanik; Judith S Kempfle; Melissa Castillo-Bustamante; Cheryl Fikucki; Michael J Wang; Elliott D Kozin; Aaron K Remenschneider
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-06-11

3.  Long-term follow-up after "one-shot" CO2 laser stapedotomy: is the functional outcome stable during the years?

Authors:  Bruno Sergi; Daniela Lucidi; Eugenio De Corso; Gaetano Paludetti
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-23       Impact factor: 2.503

4.  CO2 laser stapedotomy safety: influence of laser energy and time on bone-conduction hearing levels.

Authors:  Uwe Schönfeld; Hu Weiming; Veit M Hofmann; Sergije Jovanovic; Andreas E Albers
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-10-11       Impact factor: 2.503

5.  High-frequency hearing, tinnitus, and patient satisfaction with stapedotomy: A randomized prospective study.

Authors:  Dan Bagger-Sjöbäck; Karin Strömbäck; Malou Hultcrantz; Georgios Papatziamos; Henrik Smeds; Niklas Danckwardt-Lillieström; Bo Tideholm; Ann Johansson; Sten Hellström; Pierre Hakizimana; Anders Fridberger
Journal:  Sci Rep       Date:  2015-08-21       Impact factor: 4.379

6.  Effectiveness of stapedotomy in improving hearing sensitivity for 53 otosclerotic patients: retrospective review.

Authors:  Farid Alzhrani; Mohammad M Mokhatrish; Murad O Al-Momani; Hassan Alshehri; Abdulrahman Hagr; Soha N Garadat
Journal:  Ann Saudi Med       Date:  2017 Jan-Feb       Impact factor: 1.526

7.  A randomised, double blind trial of N-Acetylcysteine for hearing protection during stapes surgery.

Authors:  Dan Bagger-Sjöbäck; Karin Strömbäck; Pierre Hakizimana; Jan Plue; Christina Larsson; Malou Hultcrantz; Georgios Papatziamos; Henrik Smeds; Niklas Danckwardt-Lillieström; Sten Hellström; Ann Johansson; Bo Tideholm; Anders Fridberger
Journal:  PLoS One       Date:  2015-03-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.